TC
VIVO

Truvestments Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Truvestments Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-140
Closed -$3K – 670
2021
Q3 		$3K Hold
140
– – ﹤0.01% 524
2021
Q2 		$3K Hold
140
– – ﹤0.01% 533
2021
Q1 		$4K Hold
140
– – ﹤0.01% 555
2020
Q4 		$2K Buy
+140
New +$2.61K ﹤0.01% 574
2018
Q3 		$1K Buy
+57
New +$884 ﹤0.01% 858

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Truvestments Capital's VIVO Position: Q4 2021 in Review

Truvestments Capital sold out of Meridian Bioscience Inc (VIVO) in Q4 2021, closing a stake of 140 shares — an estimated $3K sold.

Truvestments Capital first reported a position in VIVO in Q3 2018 and held it in 5 quarters. The position peaked at $4K in Q1 2021. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2021.

  • Truvestments Capital reported no remaining Meridian Bioscience Inc position as of Q4 2021 after selling out during the quarter.
  • Truvestments Capital sold 140 Meridian Bioscience Inc shares in Q4 2021, an estimated $3K.
  • Truvestments Capital first reported a position in Meridian Bioscience Inc in Q3 2018 and held it in 5 quarters.
  • Truvestments Capital's Meridian Bioscience Inc position peaked at $4K in Q1 2021.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2021.

Based on Truvestments Capital's 13F filing for Q4 2021, filed 14 Feb 2022.